Cargando…
Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography‐fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3–5
OBJECTIVES: To evaluate the detection rates of clinically significant prostate cancer classified according to the prostate imaging reporting and data system scoring system using magnetic resonance imaging/ultrasound rigid fusion targeted biopsy. METHODS: A total of 339 patients underwent transperine...
Autores principales: | Hakozaki, Yuji, Matsushima, Hisashi, Murata, Taro, Masuda, Tomoko, Hirai, Yoko, Oda, Mai, Kawauchi, Nobuo, Yokoyama, Munehiro, Kume, Haruki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379286/ https://www.ncbi.nlm.nih.gov/pubmed/30461076 http://dx.doi.org/10.1111/iju.13842 |
Ejemplares similares
-
A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer
por: Hakozaki, Yuji, et al.
Publicado: (2017) -
Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018) -
Two cases of prostate cancer with disseminated carcinomatosis of the bone marrow treated with novel hormonal agents
por: Nozaki, Keina, et al.
Publicado: (2023) -
Magnetic resonance imaging /ultrasonography fusion transperineal prostate biopsy for prostate cancer: Initial experience at a Middle Eastern tertiary medical centre
por: El-Achkar, Adnan, et al.
Publicado: (2021) -
Transperineal Prostate Biopsy Targeted by Magnetic Resonance Imaging Cognitive Fusion
por: Drăgoescu, Petru Octavian, et al.
Publicado: (2023)